Zahir Amoura
#130,360
Most Influential Person Now
Zahir Amoura's AcademicInfluence.com Rankings
Zahir Amourabiology Degrees
Biology
#8563
World Rank
#11661
Historical Rank
Immunology
#495
World Rank
#512
Historical Rank
Download Badge
Biology
Zahir Amoura's Degrees
- PhD Immunology Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Zahir Amoura Influential?
(Suggest an Edit or Addition)Zahir Amoura's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. (2009) (2041)
- Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 (1999) (1479)
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis (2012) (885)
- IgA dominates the early neutralizing antibody response to SARS-CoV-2 (2020) (734)
- Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients (2009) (585)
- High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. (2012) (549)
- EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) (511)
- Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. (2013) (488)
- Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus1 (2005) (465)
- The immune paradox of sarcoidosis and regulatory T cells (2006) (426)
- Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort (2020) (402)
- Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. (2010) (379)
- CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. (2011) (336)
- Human FoxP3+ regulatory T cells in systemic autoimmune diseases. (2011) (318)
- Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. (2016) (309)
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis. (2020) (307)
- Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. (2003) (277)
- Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. (2006) (270)
- Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. (2000) (257)
- Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus☆ (1992) (248)
- Mortality in Behçet's disease. (2010) (239)
- Cardiovascular Involvement, an Overlooked Feature of Erdheim-Chester Disease: Report of 6 New Cases and a Literature Review (2004) (236)
- A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. (2020) (233)
- Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. (2012) (230)
- Late-Onset Systemic Lupus Erythematosus: A Personal Series of 47 Patients and Pooled Analysis of 714 Cases in the Literature (2004) (225)
- Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease. (2015) (225)
- Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. (1994) (219)
- Pathogenesis of Takayasu's arteritis: a 2011 update. (2011) (215)
- Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine (2020) (202)
- Reactive haemophagocytic syndrome in adult-onset Still’s disease: a report of six patients and a review of the literature (2006) (199)
- Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. (1997) (192)
- Spectrum of Cardiac Lesions in Behçet Disease: A Series of 52 Patients and Review of the Literature (2012) (190)
- Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. (2014) (188)
- Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies (2017) (187)
- Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease. (2014) (185)
- Microbial ecology perturbation in human IgA deficiency (2018) (185)
- Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. (2011) (184)
- Neurological complications of primary Sjögren's syndrome (2001) (182)
- The key role of nucleosomes in lupus. (1999) (176)
- Long-Term Outcome of Arterial Lesions in Behçet Disease: A Series of 101 Patients (2012) (166)
- Immunosuppressants reduce venous thrombosis relapse in Behçet's disease. (2012) (166)
- Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus (2007) (164)
- Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study) (2012) (164)
- Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. (2014) (161)
- Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients. (2006) (160)
- Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? (2009) (160)
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study (2021) (158)
- STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. (2009) (156)
- Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. (2005) (153)
- Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome (2016) (151)
- Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients. (2011) (150)
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials (2016) (149)
- Mortality Associated With Systemic Lupus Erythematosus in France Assessed by Multiple‐Cause‐of‐Death Analysis (2014) (149)
- Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. (1997) (149)
- Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. (1995) (149)
- Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. (2002) (148)
- Acute renal infarction: a case series. (2013) (148)
- Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. (2016) (147)
- Takayasu Arteritis in France: A Single-Center Retrospective Study of 82 Cases Comparing White, North African, and Black Patients (2010) (147)
- Histiocytoses: emerging neoplasia behind inflammation. (2017) (146)
- Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. (2006) (146)
- Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. (2004) (145)
- Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. (2006) (139)
- European consensus statement on the terminology used in the management of lupus glomerulonephritis (2009) (137)
- Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. (2012) (133)
- Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. (2010) (133)
- Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. (2009) (133)
- Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans (2015) (131)
- The Systemic Capillary Leak Syndrome: A Case Series of 28 Patients From a European Registry (2011) (131)
- Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases. (2007) (130)
- Characteristics and Long-Term Outcome of 15 Episodes of Systemic Lupus Erythematosus-Associated Hemophagocytic Syndrome (2006) (128)
- Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature. (2012) (127)
- Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease. (2011) (126)
- FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. (2009) (125)
- Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease (2005) (124)
- Exhausted Cytotoxic Control of Epstein-Barr Virus in Human Lupus (2011) (124)
- Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block (2003) (123)
- Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome. (2010) (122)
- Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients. (2015) (121)
- Hydroxychloroquine in systemic lupus erythematosus (2007) (120)
- Images in cardiovascular medicine. Cardiac involvement in Erdheim-Chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients. (2009) (120)
- Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature. (2010) (118)
- Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature (2008) (114)
- Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study). (2017) (114)
- Lupus enteritis: from clinical findings to therapeutic management (2013) (114)
- BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. (2009) (113)
- Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival (2013) (111)
- Cardiomyopathy Related to Antimalarial Therapy with Illustrative Case Report (2006) (110)
- Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies. (2015) (109)
- Prevalence and severity of malnutrition in hospitalized COVID-19 patients (2020) (108)
- Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus (2015) (108)
- Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome. (2015) (108)
- Erdheim–Chester disease (2012) (107)
- Characteristics and Management of IgA Vasculitis (Henoch‐Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey (2017) (106)
- Prevalence and incidence of systemic lupus erythematosus in France: a 2010 nation-wide population-based study. (2014) (104)
- Evidence of transplacental passage of hydroxychloroquine in humans. (2002) (104)
- Anakinra in Adult‐Onset Still's Disease: Long‐Term Treatment in Patients Resistant to Conventional Therapy (2013) (101)
- Epidemiology of Primary Sjögren's Syndrome in a French Multiracial/Multiethnic Area (2014) (100)
- Pathogenesis of relapsing polychondritis: a 2013 update. (2014) (100)
- Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature (2008) (96)
- Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis (2011) (95)
- Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease (2000) (95)
- Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions (2012) (94)
- The role of nucleosomes in lupus (2000) (94)
- Renal toxicities associated with pembrolizumab (2018) (93)
- Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France (2001) (93)
- Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19 (2020) (93)
- Erdheim–Chester Disease (2014) (93)
- Inflammatory Myopathies With Anti-Ku Antibodies: A Prognosis Dependent on Associated Lung Disease (2012) (92)
- Tumor Antigen Markers for the Detection of Solid Cancers in Inflammatory Myopathies (2005) (92)
- Peripheral Neuropathies Associated With Primary Sjögren Syndrome: Immunologic Profiles of Nonataxic Sensory Neuropathy and Sensorimotor Neuropathy (2011) (91)
- Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study. (2013) (91)
- Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options (2005) (90)
- Treatment of Erdheim-Chester disease with long-term high-dose interferon-α. (2012) (89)
- Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients. (2017) (88)
- IFNα kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model (2009) (88)
- 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. (2009) (88)
- Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen (2009) (88)
- Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil. (2010) (88)
- Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature. (2015) (86)
- Granulomatosis-associated common variable immunodeficiency disorder: a case–control study versus sarcoidosis (2012) (86)
- NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis (2010) (85)
- High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis. (2017) (85)
- Low rate of daily active tobacco smoking in patients with symptomatic COVID-19 (2020) (85)
- Renal effects of immune checkpoint inhibitors (2016) (83)
- QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation. (2011) (83)
- Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: A meta-analysis of the literature. (2014) (81)
- Cerebral venous thrombosis in Behçet's disease. (2009) (80)
- Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis. (2008) (80)
- Binding of nucleosomes to a cell surface receptor: Redistribution and endocytosis in the presence of lupus antibodies (1996) (80)
- Azathioprine in severe uveitis of Behçet's disease (2010) (80)
- Phenotypes and survival in Erdheim‐Chester disease: Results from a 165‐patient cohort (2018) (79)
- Patterns of systemic lupus erythematosus expression in Europe. (2014) (79)
- Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. (2017) (78)
- High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. (2003) (76)
- Long-term outcomes of refractory neurosarcoidosis treated with infliximab (2017) (75)
- Clinical Phenotypes of Patients with Anti-DFS70/LEDGF Antibodies in a Routine ANA Referral Cohort (2013) (75)
- Late-Onset Systemic Lupus Erythematosus (2012) (75)
- Nucleosomes in the pathogenesis of systemic lupus erythematosus. (2004) (75)
- Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. (2004) (74)
- Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients (2017) (74)
- Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. (1998) (74)
- Erdheim-Chester disease: CT findings of thoracic involvement (2010) (73)
- Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides (2008) (72)
- Lupus Anticoagulant-Hypoprothrombinemia Syndrome: Report of 8 Cases and Review of the Literature (2012) (72)
- Hepatitis C virus–associated polyarteritis nodosa (2011) (72)
- Spinal Cord Sarcoidosis: Clinical and Laboratory Profile and Outcome of 31 Patients in a Case-Control Study (2010) (71)
- Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial (2019) (70)
- Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units (2020) (70)
- Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report (2011) (70)
- Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients. (2013) (69)
- The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature (2012) (68)
- Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients. (2009) (67)
- Systemic lupus erythematosus: state of the art on clinical practice guidelines (2018) (67)
- Annual direct medical cost of active systemic lupus erythematosus in five European countries (2012) (67)
- Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use. (2016) (66)
- Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease. (2005) (66)
- Hematological malignancy associated with polymyositis and dermatomyositis. (2012) (65)
- Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis. (2006) (65)
- High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability? (2020) (65)
- Feto‐maternal microchimerism in connective tissue diseases (2002) (64)
- Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making (2008) (64)
- Medical and developmental risk factors of catatonia in children and adolescents: A prospective case–control study (2012) (64)
- Phenotype-Haplotype Correlation of IRF5 in Systemic Sclerosis: Role of 2 Haplotypes in Disease Severity (2010) (64)
- Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block (2005) (63)
- Synergistic convergence of microbiota‐specific systemic IgG and secretory IgA (2019) (63)
- Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus (2015) (63)
- Changes in Enoxaparin Pharmacokinetics During Pregnancy and Implications for Antithrombotic Therapeutic Strategy (2008) (63)
- Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients. (2017) (63)
- Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group. (1997) (62)
- Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE. (2015) (62)
- Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up (2014) (61)
- Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity. (2012) (61)
- Treatment of neurosarcoidosis (2016) (60)
- Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry. (2011) (60)
- Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation. (2010) (60)
- The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus. (1999) (60)
- Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. (2011) (59)
- Antisynthetase Syndrome with Anti-Jo1 Antibodies in 48 Patients: Pulmonary Involvement Predicts Disease-modifying Antirheumatic Drug Use (2012) (59)
- Erdheim-Chester disease. (2020) (58)
- Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome. (2004) (58)
- Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome. (2017) (58)
- Anetoderma and its prothrombotic abnormalities. (2003) (58)
- Targeting Interferons in Systemic Lupus Erythematosus: Current and Future Prospects (2015) (57)
- Calreticulin, a Potential Cell Surface Receptor Involved in Cell Penetration of Anti-DNA Antibodies1 (2001) (57)
- Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis (2016) (56)
- The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. (2012) (56)
- The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu's arteritis: a study of 43 patients. (2000) (56)
- Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients. (2011) (56)
- Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. (2003) (55)
- Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide. (2013) (55)
- Efficacy of the MEK inhibitor cobimetinib for wild‐type BRAF Erdheim‐Chester disease (2018) (55)
- In Antisynthetase Syndrome, ACPA Are Associated With Severe and Erosive Arthritis (2015) (53)
- Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome? (2012) (53)
- Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor (2011) (53)
- Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry (2018) (53)
- HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome. (2018) (53)
- Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases. (2013) (53)
- Endocrine Manifestations in a Monocentric Cohort of 64 Patients With Erdheim-Chester Disease. (2016) (52)
- Cutaneous manifestations of Erdheim-Chester disease (ECD): Clinical, pathological, and molecular features in a monocentric series of 40 patients. (2016) (52)
- Long‐term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies (2011) (52)
- Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases (2007) (51)
- Bilateral adrenal infiltration in Erdheim-Chester disease. Report of seven cases and literature review. (2007) (51)
- The Clinical Picture of Severe Systemic Capillary-Leak Syndrome Episodes Requiring ICU Admission (2017) (51)
- C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysis. (2011) (51)
- Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus. (2011) (50)
- The spectrum of kidney biopsies in hospitalized patients with COVID-19, acute kidney injury, and/or proteinuria (2021) (50)
- Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. (2010) (49)
- IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells (2011) (49)
- Sjögren Syndrome-Associated Small Fiber Neuropathy (2013) (48)
- Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases. (2017) (48)
- Pharmacokinetic Study of Mycophenolate Mofetil in Patients with Systemic Lupus Erythematosus and Design of Bayesian Estimator Using Limited Sampling Strategies (2008) (48)
- Potentiation of Vitamin K Antagonists by High-Dose Intravenous Methylprednisolone (2000) (48)
- BRAF mutations in Erdheim-Chester disease. (2013) (48)
- Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease. (2016) (48)
- Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature. (2018) (47)
- Amyloidosis and cardiac involvement. (2000) (47)
- Diabetes mellitus after abdominal radiation therapy (1995) (47)
- Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse (2019) (46)
- Brief Report: A Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled, Multiple‐Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis (2018) (46)
- LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus. (2012) (45)
- Ocular Whipple's disease: therapeutic strategy and long-term follow-up. (2012) (45)
- Pseudotumoural presentation of neuro-Behcet's disease: case series and review of literature. (2012) (45)
- Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. (2000) (45)
- Drug‐induced sarcoidosis: an overview of the WHO pharmacovigilance database (2020) (44)
- Small vessel involvement in Takayasu's arteritis. (2013) (44)
- Drug-induced hemophagocytosis. (2002) (44)
- Efficacy and safety of rituximab for systemic lupus erythematosus‐associated immune cytopenias: A multicenter retrospective cohort study of 71 adults (2018) (43)
- Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus (2011) (43)
- Ovarian vein thrombosis in the antiphospholipid syndrome. (2004) (43)
- [Pathophysiology of Behcet's disease]. (2006) (42)
- A New Presentation of Neonatal Lupus: 5 Cases of Isolated Mild Endocardial Fibroelastosis Associated with Maternal Anti-SSA/Ro and Anti-SSB/La Antibodies (2011) (42)
- Familial inflammatory inclusion body myositis (2005) (41)
- Kikuchi-Fujimoto Disease (2014) (41)
- Monitoring Disease Activity in Systemic Lupus Erythematosus With Single‐Molecule Array Digital Enzyme‐Linked Immunosorbent Assay Quantification of Serum Interferon‐α (2019) (41)
- Erdheim-Chester disease. (2013) (41)
- Distinct cytokine profiles associated with COVID-19 severity and mortality (2021) (40)
- Cluster analysis of arterial involvement in Takayasu arteritis reveals symmetric extension of the lesions in paired arterial beds. (2011) (40)
- Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis (2017) (40)
- The histiocytosis Erdheim–Chester disease is an inflammatory myeloid neoplasm (2015) (40)
- Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim–Chester Disease, Destombes–Rosai–Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders (2019) (39)
- Regulatory T Cell Responses to High-Dose Methylprednisolone in Active Systemic Lupus Erythematosus (2015) (38)
- Sjögren Sensory Neuronopathy (Sjögren Ganglionopathy) (2016) (38)
- [Neurological manifestations of antiphospholipid syndrome]. (1998) (38)
- Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study (2020) (38)
- Shrinking lung syndrome associated with systemic lupus erythematosus: A multicenter collaborative study of 15 new cases and a review of the 155 cases in the literature focusing on treatment response and long-term outcomes. (2016) (37)
- Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment? (2010) (37)
- BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus (2021) (37)
- Independent Replication and Metaanalysis of Association Studies Establish TNFSF4 as a Susceptibility Gene Preferentially Associated with the Subset of Anticentromere-positive Patients with Systemic Sclerosis (2012) (37)
- Antiphospholipid syndrome: state of the art on clinical practice guidelines (2018) (37)
- AL cardiac amyloidosis and arterial thromboembolic events (2005) (36)
- Concomitant diagnosis of primary Sjögren's syndrome and systemic AL amyloidosis (2001) (36)
- Antinuclear antibodies in relapsing polychondritis (1999) (36)
- Case study: effectiveness of plasma exchange in an adolescent with systemic lupus erythematosus and catatonia. (2003) (36)
- Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. (1992) (35)
- Absence of Mycobacterium tuberculosis in Arterial Lesions from Patients with Takayasu’s Arteritis (2009) (35)
- Ultrasound, elastography, and fluorodeoxyglucose positron emission tomography/computed tomography imaging in Riedel's thyroiditis: report of two cases. (2011) (34)
- Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review (2014) (33)
- Plasma Exchange in Patients with Stuporous Catatonia and Systemic Lupus Erythematosus (2008) (32)
- Ultraviolet light converts propranolol, a nonselective β‐blocker and potential lupus‐inducing drug, into a proinflammatory AhR ligand (2015) (31)
- Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study (2018) (30)
- Efficacy of Biological-Targeted Treatments in Takayasu ArteritisCLINICAL PERSPECTIVE (2015) (30)
- Testing for anti-nucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients (2003) (30)
- Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists (2018) (30)
- High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for adult histiocytic disorders with central nervous system involvement. (2006) (29)
- Pulmonary hyalinizing granuloma: a multicenter study of 5 new cases and review of the 135 cases of the literature (2017) (28)
- Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases (2007) (28)
- Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1 (2020) (28)
- [Treatment of systemic lupus erythematosus]. (2011) (27)
- Response to: ‘Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’’ by Nikpour et al (2020) (27)
- International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. (2017) (27)
- Erdheim-Chester Disease: a Concise Review (2019) (26)
- Corrected QT interval in anti-SSA-positive adults with connective tissue disease: comment on the article by Lazzerini et al. (2005) (26)
- A causality algorithm to guide diagnosis and treatment of catatonia due to autoimmune conditions in children and adolescents (2017) (26)
- Early anti‐nucleosome autoantibodies from a single MRL +/+ mouse: fine specificity, V gene structure and pathogenicity (1998) (25)
- The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET (2021) (25)
- Treatment of Progressive Systemic Sclerosis by Plasma Exchange: Long-term Results in 40 Patients (1990) (25)
- The cerebrospinal fluid CD4/CD8 ratio and interleukin‐6 and ‐10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study (2019) (25)
- Mixed connective tissue disease: state of the art on clinical practice guidelines (2018) (25)
- The importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus. (2011) (25)
- Association Study of ITGAM, ITGAX, and CD58 Autoimmune Risk Loci in Systemic Sclerosis: Results from 2 Large European Caucasian Cohorts (2011) (25)
- [Plasma exchange]. (1989) (25)
- Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: Clinical and immunological features: A propos of 40 new cases and review of the literature. (2010) (24)
- Efficacy of infliximab in the treatment of Erdheim-Chester disease (2018) (24)
- Le syndrome catastrophique des antiphospholipides (2012) (24)
- Skeletal muscle lymphoma in patients with the acquired immunodeficiency syndrome: a diagnostic challenge. (1993) (23)
- Multiparameter grouping delineates heterogeneous populations of human IL‐17 and/or IL‐22 T‐cell producers that share antigen specificities with other T‐cell subsets (2011) (23)
- Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cells (2016) (23)
- Massive ovarian haemorrhage complicating oral anticoagulation in the Antiphospholipid Syndrome: a report of three cases (1999) (23)
- Marked efficacy of vemurafenib in suprasellar Erdheim-Chester disease (2014) (22)
- Erdheim-Chester disease. (2014) (22)
- Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study (2018) (22)
- Clinicopathological features of multiple mononeuropathy associated with systemic lupus erythematosus: a multicenter study (2017) (22)
- Clinical, imaging, and histological presentations and outcomes of stroke related to sarcoidosis (2018) (21)
- Hemochromatosis and femoral head aseptic osteonecrosis: a nonfortuitous association? (2005) (21)
- SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease) (2020) (21)
- Transplacental passage of colchicine in familial Mediterranean fever. (1994) (21)
- IgG4-related diseases: state of the art on clinical practice guidelines (2019) (21)
- Central nervous system angiitis: a series of 31 patients (2013) (20)
- High frequency of clonal hematopoiesis in Erdheim-Chester disease. (2020) (20)
- Highly sensitive methods are required to detect mutations in histiocytoses (2018) (20)
- Vemurafenib as first line therapy in BRAF-mutated Langerhans cell histiocytosis. (2015) (20)
- Thrombophilia Associated with Anti-DFS70 Autoantibodies (2015) (20)
- Epithelioid sarcoma mimicking abscess: review of the MRI appearances (2001) (20)
- Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome (2011) (19)
- Neuro-Behçet's disease (isolated cerebral thrombophlebitis excluded). Clinical pattern, prognostic factors, treatment and long term follow-up. (2003) (19)
- Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels (2016) (19)
- COVID‐19‐associated collapsing glomerulopathy: a report of two cases and literature review (2020) (18)
- Giant-cell arteritis-related mortality in France: A multiple-cause-of-death analysis. (2018) (18)
- Collapsing glomerulopathy in systemic autoimmune disorders: a case occurring in the course of full blown systemic lupus erythematosus (2006) (18)
- Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barré Syndrome (2008) (18)
- Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis (2020) (18)
- Anti-synthetase syndrome positive for anti-isoleucyl-tRNA synthetase antibodies: an unusual case overlapping with systemic sclerosis and Sjogren's syndrome. (2011) (17)
- [Efficacy of colchicine in recurrent acute idiopathic pericarditis]. (2000) (17)
- Real Time Identification of Drug-Induced Liver Injury (DILI) through Daily Screening of ALT Results: A Prospective Pilot Cohort Study (2012) (17)
- Low rate of daily smokers in patients with symptomatic COVID-19 (2020) (17)
- Hyperthyroidism-associated chorea (1998) (17)
- Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosis. (2011) (16)
- Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases (2003) (16)
- Symptomatic muscular sarcoidosis (2018) (16)
- Type B Insulin-resistance syndrome: a cause of reversible autoimmune hypoglycaemia (2014) (16)
- Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis. (2007) (16)
- Lenalidomide Therapy in Nine Patients with POEMS Syndrome. (2009) (16)
- [Idiopathic and secondary capillary leak syndromes: A systematic review of the literature]. (2015) (16)
- Patterns of fatigue and association with disease activity and clinical manifestations in systemic lupus erythematosus. (2020) (16)
- Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines (2019) (16)
- Histiocytosis and the nervous system: from diagnosis to targeted therapies (2021) (15)
- Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia (2000) (15)
- Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans Cell Histiocytosis. (2019) (15)
- Gastrointestinal involvement in adult IgA vasculitis (Henoch-Schönlein purpura): updated picture from a French multicentre and retrospective series of 260 cases. (2020) (15)
- Lung involvement in Destombes-Rosai-Dorfman disease: clinical and radiological features and response to the MEK inhibitor cobimetinib. (2020) (14)
- HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa. (2013) (14)
- [Treatment of systemic lupus erythematosus]. (2011) (14)
- Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim–Chester disease (2016) (14)
- Aortic involvement in relapsing polychondritis. (2017) (14)
- Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study. (2009) (13)
- Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment (2019) (13)
- Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study. (2019) (13)
- Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease (2018) (13)
- Renal microaneurysms in three cases of hepatitis C virus-related vasculitis. (2002) (13)
- Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety. (2020) (13)
- Autoimmunity associated with Erdheim-Chester disease improves with BRAF/MEK inhibitors (2019) (12)
- [Rosai-Dorfman disease: Diagnosis and therapeutic challenges]. (2018) (12)
- Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults (2022) (12)
- Pre-COVID-19 humoral immunity to common coronaviruses does not confer cross-protection against SARS-CoV-2 (2020) (12)
- [Anti-beta 2 glycoprotein I antibodies in systemic lupus erythematosus: a marker of thrombosis associated with a circulating anticoagulant]. (1991) (12)
- Cerebrovascular events are associated with lower survival in giant cell arteritis: A case-controlled multicenter study. (2017) (12)
- Lupus and vaccinations (2018) (12)
- One-year outcome of critically ill patients with systemic rheumatic disease: a multicenter cohort study. (2020) (12)
- [Gougerot-Sjögren syndrome. Neurologic complications]. (1999) (12)
- Whole-body MRI in Erdheim-Chester disease. (2012) (11)
- Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort (2020) (11)
- Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter (2019) (11)
- Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: a multicenter retrospective observational study of 40 patients. (2020) (11)
- Pentoxifylline-induced aseptic meningitis in a patient with mixed connective tissue disease (2002) (11)
- Detection in whole blood of autoantibodies for the diagnosis of connective tissue diseases in near patient testing condition (2018) (11)
- Anti-β2-Glycoprotein I antibodies and thrombosis (1995) (10)
- Myocardial dysfunction is frequent in systemic capillary-leak syndrome (Clarkson disease) severe episodes. (2018) (10)
- Evolution of Nutritional Status after Early Nutritional Management in COVID-19 Hospitalized Patients (2021) (10)
- OP0164 BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS (2020) (10)
- Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody–associated Vasculitis-related Bronchiectasis: Data from 61 Patients (2019) (10)
- Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α (2022) (10)
- Chronic Malaria Revealed by a New Fluorescence Pattern on the Antinuclear Autoantibodies Test (2014) (10)
- BNT 162 b 2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus (2021) (10)
- Lower Rate of Daily Smokers With Symptomatic COVID-19: A Monocentric Self-Report of Smoking Habit Study (2022) (10)
- Association study of 3 rheumatoid arthritis risk loci in systemic sclerosis in European Caucasian population. (2011) (10)
- Characteristics, outcome and treatments with cranial pachymeningitis (2018) (10)
- [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia]. (2017) (10)
- Antinucleosome antibodies and systemic lupus erythematosus. (1997) (10)
- Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence (2020) (9)
- Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients (2021) (9)
- Disease-specific quality of life following a flare in systemic lupus erythematosus: an item response theory analysis of the French EQUAL cohort. (2020) (9)
- OP0064 Joint EULAR/ERA-EDTA recommendations for the management of adult and pediatric lupus nephritis (2013) (9)
- [Neurosarcoidosis: Diagnosis and therapeutic issues]. (2017) (9)
- Correspondence on ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ (2020) (9)
- Candidate Gene Study in Systemic Sclerosis Identifies a Rare and Functional Variant of the TNFAIP 3 Locus as a Risk Factor for Polyautoimmunity (2012) (9)
- F-18 FDG-PET/CT in aseptic abscesses with recurrent febrile abdominal pain (2011) (9)
- [Idiopathic capillary leak syndrome]. (2009) (9)
- The Exostosin Immunohistochemical Status Differentiates Lupus Membranous Nephropathy Subsets With Different Outcomes (2021) (9)
- Successful treatment of combined proliferative and membranous lupus nephritis using a full corticosteroid-free regimen (2013) (9)
- Systemic lupus erythematosus with anti-Hu antibodies and polyradiculoneuropathy (2001) (8)
- Valvular heart disease and systemic lupus erythematosus. (1997) (8)
- [Erdheim-Chester disease]. (2014) (8)
- [Pulmonary arterial hypertension in systemic lupus erythematosus]. (2011) (8)
- Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients (2021) (8)
- Cerebral pseudo-tumoral neuro-Behcet: Histological demonstration of an inflammatory and vascular disease (2017) (8)
- Psychiatric autoimmune conditions in children and adolescents: Is catatonia a severity marker? (2020) (8)
- Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic) (2021) (8)
- Anticorps antiphospholipides en pratique (2012) (8)
- [Small fibre neuropathy: Diagnostic approach and therapeutic issues, and its association with primary Sjögren's syndrome]. (2010) (8)
- Persistent deficiency of mucosal-associated invariant T cells during dermatomyositis. (2019) (8)
- Impaired carbon monoxide diffusing capacity as a marker of limited systemic sclerosis. (2011) (8)
- Spinal Koebner phenomenon: Medullar sarcoidosis facing a discal hernia. (2017) (8)
- Lupus érythémateux disséminé chez l'enfant : recommandations concernant les examens à effectuer lors de l'évaluation initiale et du suivi Guidelines about investigations to be performed at the diagnosis and during the follow-up of childhood-onset systemic lupus erythematosus (2004) (8)
- Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations (2020) (8)
- Successful extracorporeal membrane oxygenation for refractory cardiogenic shock due to the catastrophic antiphospholipid syndrome. (2010) (8)
- Ivermectin as a potential treatment for COVID-19? (2021) (8)
- Development and validation of a fast U-HPLC-fluorescent method for the quantification of hydroxychloroquine and its metabolites in patients with lupus. (2019) (7)
- Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics. (2020) (7)
- Fatal progressive systemic sclerosis following autologous stem cell transplantation and high-dose chemotherapy. (2005) (7)
- [Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: A retrospective multicentric study of 28 adult cases]. (2017) (7)
- Systemic lupus erythematosus in patients native to West and Central Africa: comment on the article by Bae et al. (1999) (7)
- Syndrome des antiphospholipides et polychondrite atrophiante (1997) (7)
- In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU Admission (2020) (7)
- [Cytokines and T cell differentiation in systemic sclerosis]. (2011) (7)
- [Vitamin D and autoimmunity. Second part: Clinical aspects]. (2012) (7)
- LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications (2021) (7)
- New insights on IgA vasculitis with underlying solid tumor: a nationwide French study of 30 patients (2020) (7)
- Sarcoidosis diagnosed on granulomas in the explanted heart after transplantation: Results of a French nationwide study. (2020) (7)
- [Infectious aneurysm due to Listeria monocytogenes: a new case and review of the literature]. (1998) (7)
- Mesenteric Venous Thrombosis in Two Patients Heterozygous for the 20210 A Allele of the Prothrombin Gene (1998) (7)
- [Neonatal lupus syndrome: review of the literature]. (2003) (7)
- Catatonia and Autoimmune Conditions in Children and Adolescents: Should We Consider a Therapeutic Challenge? (2017) (6)
- Acute Tubular Injury and Renal Arterial Myocyte Vacuolization Following Crizotinib Administration (2020) (6)
- [Central nervous system involvement in systemic diseases: Spectrum of MRI findings]. (2010) (6)
- Are script concordance tests suitable for the assessment of undergraduate students? A multicenter comparative study. (2020) (6)
- [Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion]. (2016) (6)
- Characterization of Interstitial Lung Disease Associated With Anti-Ribonucleoprotein Antibodies (2019) (6)
- [Role of the nucleosome in the physiopathology of systemic lupus erythematosus]. (2003) (6)
- Neovascular glaucoma after bypass surgery in Takayasu's disease (1999) (6)
- LOX-1+ immature neutrophils predict severe COVID-19 patients at risk of thrombotic complications (2020) (6)
- Anti-beta 2-glycoprotein I antibodies and thrombosis. (1995) (6)
- Sarcoidosis occurring during BRAF/MEK inhibitors is associated with paradoxical ERK activation in Erdheim‐Chester patients (2019) (6)
- [Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion]. (2015) (6)
- Response to Letter: ‘Reply to “High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?”’ (2020) (6)
- Interferon-alpha in cardiac Erdheim-Chester disease. (2011) (5)
- [Assessment of patient needs to design a patient education program in systemic lupus erythematosus]. (2014) (5)
- [Hydroxychloroquine and systemic lupus: a reappraisal]. (2008) (5)
- [Vitamin D and autoimmunity. First part: Fundamental aspects]. (2012) (5)
- [Treatment of systemic diseases with pulse cyclophosphamide: 15 cases]. (1990) (5)
- Severe Viral Myopericarditis With Autoantibodies Directed Against RNA Polymerase III (2019) (5)
- Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases. (2020) (5)
- Proceedings of Réanimation 2017, the French Intensive Care Society International Congress (2017) (5)
- Letter by Guettrot-Imbert et al regarding article, "early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies". (2009) (5)
- [Cancers associated with systemic sclerosis involving anti-RNA polymerase III antibodies]. (2018) (5)
- The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET. (2022) (5)
- [Pleading to maintain hydroxychloroquine throughout Lupus pregnancies]. (2005) (5)
- Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial (2022) (5)
- Routine use of Zenit RA, a novel chemiluminescent immunoanalyzer in autoimmune disease diagnosis (2012) (5)
- [Obstetrical management of patients at risk of neonatal lupus syndrome: review of the literature]. (2006) (5)
- Clonal Hematopoiesis in Erdheim-Chester Disease (2017) (5)
- Workload, well-being and career satisfaction among French internal medicine physicians and residents in 2018 (2019) (5)
- Human lupus, fewer Treg cells indeed: comment on the article by Venigalla et al. (2009) (5)
- [Antiphospholipid antibody/cofactors. What are they? Why, when and how to search for them? Is treatment justified?]. (1996) (5)
- OP0166 ALTERNATIVE RENAL RESPONSE DEFINITIONS IN A RANDOMIZED, CONTROLLED TRIAL OF OBINUTUZUMAB FOR PROLIFERATIVE LUPUS NEPHRITIS (2020) (5)
- Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation (2022) (5)
- CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission. (2019) (5)
- Clarkson’s Disease Episode or Secondary Systemic Capillary Leak-Syndrome (2021) (4)
- Clinical phenotypes of extra-pulmonary sarcoidosis. The EpiSarc study (2018) (4)
- Lupus band test yields negative results in primary antiphospholipid syndrome. (2001) (4)
- Subcutaneous immunoglobulins for the treatment of a patient with antisynthetase syndrome and secondary chronic immunodeficiency after anti-CD20 treatment: a case report (2017) (4)
- Proceedings of Réanimation 2017, the French Intensive Care Society International Congress (2017) (4)
- mTOR: a new target in Erdheim-Chester disease? (2015) (4)
- Manifestations neurologiques du syndrome des antiphospholipides (1998) (4)
- Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature. (2021) (4)
- Central nervous system involvement in Erdheim-Chester disease (2020) (4)
- Immune phenotyping of Erdheim-Chester disease through mass cytometry highlights decreased proportion of non-classical monocytes and increased proportion of Th17 cells (2020) (4)
- Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity (2022) (4)
- Spontaneous remission of fully symptomatic visceral leishmaniasis (2015) (4)
- More on Ofatumumab for TTP. (2018) (4)
- Histology of Rosai-Dorfman disease in a subset of patients with Erdheim-Chester disease: A distinct entity mainly driven by MAP2K1. (2018) (4)
- [Physiopathology of systemic lupus erythematosus: a 2014 update]. (2014) (4)
- Impact of aging on phenotype and prognosis in IgA vasculitis. (2021) (4)
- Catastrophic antiphospholipid syndrome (CAPS)-induced ischemic pancreatic ducts injury mimicking intraductal papillary mucinous neoplasm (IPMN). (2018) (4)
- [Acute hepatitis during primary herpes simplex type 2 infection in a patient with systemic lupus erythematosus]. (2007) (4)
- [Takayasu arteritis: a French single centre experience]. (2010) (4)
- Coronary artery disease in systemic lupus: A case-controlled angiographic study. (2019) (4)
- Effects of corticosteroids on bone and blood pressure. (1992) (4)
- Thrombopoietin-Receptor Agonist in Systemic Lupus Erythematosus Associated Immune Thrombocytopenia: Results of the 16 Patients from the French Cohort (2016) (3)
- Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus (2021) (3)
- In-Hospital Mortality-Associated Factors of Thrombotic Antiphospholipid Syndrome Patients Requiring Intensive Care Unit Admission. (2019) (3)
- Reducing lupus flares: should we be more careful about stopping glucocorticoids? (2020) (3)
- Correlation of BRAF V600E mutation with cardiac involvement assessed by heart imaging in a monocentric series of 205 patients with Erdheim-Chester disease. (2019) (3)
- Frequent Clinical Overlap of Histiocytic Neoplasms and WHO-Classified Myeloid Malignancies Leads to Functional Insights into the Cell-of-Origin of Histiocytoses (2016) (3)
- Long-bones involvement in generalized crystal-storing histiocytosis. (2019) (3)
- Anticancer Drug-Induced Capillary Leak Syndrome (2022) (3)
- [Assessing the cardiovascular risk in patients with systemic lupus erythematosus]. (2014) (3)
- Prevalence, patterns and outcomes of cardiac involvement in Erdheim-Chester disease. (2022) (3)
- [Salmonella typhi murium spondylodiscitis in systemic lupus]. (1988) (3)
- [Cardiac sarcoidosis: Diagnosis and therapeutic challenges]. (2017) (3)
- Outcomes of severe systemic rheumatic disease patients requiring extracorporeal membrane oxygenation (2021) (3)
- FRI0302 Systemic lupus erythematosus-associated thrombotic microangiopathies in 60 patients: clinical features, prognosis and treatment in a french multicentric cohort (2018) (3)
- Expanding the spectrum of HIV-associated myopathy (2019) (3)
- Factors associated with implantable cardioverter defibrillators appropriate therapy in cardiac sarcoidosis: a meta-analysis (2020) (3)
- Inclusion body myositis and human immunodeficiency virus type 1: A new case report and literature review (2018) (3)
- Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus (2021) (3)
- Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
- Atypical dementia (2010) (3)
- Syndrome de Gougerot-Sjögren. Complications neurologiques. (1999) (3)
- [Infection associated cerebral vasculitis]. (2020) (3)
- [Sarcoidosis flare after autologous stem cell transplantation: An immune paradox?] (2017) (3)
- Catastrophic Diagnosis of the Antiphospholipid Syndrome (1999) (3)
- Classification of vasculitis. (1999) (3)
- Neurodegeneration in histiocytoses might start in utero (2017) (3)
- Transvenous Renal Biopsy of Critically Ill Patients: Safety and Diagnostic Yield (2019) (2)
- The presence of atherosclerotic plaques in patients with Takayasu arteritis: comment on the article by Keenan et al. (2010) (2)
- [Systemic lupus erythematosus. Anti-phospholipid syndrome]. (2003) (2)
- Activated protein C and pulmonary embolism (1996) (2)
- Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature (2021) (2)
- Viscosity as the symptom leading to plasma exchange. (1990) (2)
- A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency (2019) (2)
- Treatment of relapsing polychondritis: a systematic review. (2021) (2)
- Immunohistochemical and virological features of HTLV-1-associated myosites: a study of 13 patients from West Indies and Africa (2011) (2)
- Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study (2020) (2)
- [Systemic lupus erythematosus: future therapeutic avenues]. (2008) (2)
- Prevalence and factors associated with long-term remission in cutaneous lupus: a longitudinal cohort study of 141 cases. (2022) (2)
- [Pathogenesis of primary large vessel arteritis]. (2009) (2)
- [Cost of systemic lupus erythematosus for adult patients with active and treated disease in France (LUCIE study)]. (2014) (2)
- A 75-year-old woman admitted to the ICU with respiratory failure. (2012) (2)
- [The appearance of antinucleosome antibodies precedes that of anti-double-stranded DNA and anti-histones in murine lupus]. (1993) (2)
- Response to: ‘Presence of anti-phospholipid antibodies in COVID-19: a case series study’ by Amezcua-Guerra et al (2020) (2)
- Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases. (2021) (2)
- Preventing relapses in antineutrophil cytoplasmic antibody-associated vasculitis. (2011) (2)
- [Retinopathy in acute pancreatitis]. (1999) (2)
- High Serum VEGF Level in Erdheim-Chester Disease: Correlation with Cardiovascular Involvement and Response to Treatment (2019) (2)
- [Enteroviral infections in adults treated with rituximab: A new case of chronic meningitis and myofasciitis and literature review]. (2020) (2)
- Images in cardiovascular medicine. Recurrent myocardial infarction in a patient with paroxysmal nocturnal hemoglobinuria. (2003) (2)
- The Systemic Capillary Leak Syndrome (2011) (2)
- OP0285 Assessment of Patient Needs to Design a Patient Education Program in Systemic Lupus Erythematosus (2013) (2)
- Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study). (2020) (2)
- Can Rituximab be Useful for Treating SLE-Associated Immune Cytopenias ? Results from a Retrospective Multicentre Study on 62 Patients (2016) (2)
- SAT0166 BIOMARKERS OF B-CELL DEPLETION AND RESPONSE IN A RANDOMIZED, CONTROLLED TRIAL OF OBINUTUZUMAB FOR PROLIFERATIVE LUPUS NEPHRITIS (2020) (2)
- The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim–Chester Disease (2020) (2)
- Recurrent Myocardial Infarction in a Patient With Paroxysmal Nocturnal Hemoglobinuria (2003) (2)
- Response to: ‘Implications of SARS-CoV-2 infection for patients with rheumatic disease’ by Lin et al (2020) (2)
- Handling shock in idiopathic systemic capillary leak syndrome (Clarkson’s disease): less is more—comment (2019) (2)
- POS0722 CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL AND ACCELERATED ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (HEMATOPLUS STUDY) (2022) (1)
- OP0184 Clinical Spectrum and Therapeutic Management of Systemic Lupus Erythematosus-Associated Macrophage Activation Syndrome. Data from A French Nationwide Study of 81 Episodes in 67 Adult Patients (2016) (1)
- Cutaneous Kikuchi disease-like inflammatory pattern without lymph node involvement is associated with systemic disease and severe features in lupus erythematous: A case-control study (2020) (1)
- [New therapies for autoimmune diseases]. (2006) (1)
- [Drug-induced lupus erythematosus]. (2011) (1)
- The mediating effect of fatigue in impaired quality of life in systemic lupus erythematosus: mediation analysis of the French EQUAL cohort. (2023) (1)
- Bordetella bronchiseptica Pneumonia in a Woman with Lymphoma: A Case Report (2012) (1)
- Response to ‘Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic’ by Chuah et al (2020) (1)
- BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS (2021) (1)
- OP0043 WITHDRAWAL OF A LOW DOSE (5 MG) OF CORTICOSTEROIDS IN SYSTEMIC LUPUS IN REMISSION FOR MORE THAN A YEAR IS AT RISK OF RELAPSE – THE CORTICOLUP TRIAL (2019) (1)
- Clonal hematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study). (2022) (1)
- Systemic chloroquine intoxication: a hint from the peripheral blood smear (2020) (1)
- The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease) (2021) (1)
- [Skin pigmentation in a patient with systemic lupus erythematosus]. (2010) (1)
- Response to: ‘Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak’ by Holubar et al (2020) (1)
- Pure Red Cell Aplasia in Systemic Lupus Erythematosus, a Nationwide Retrospective Cohort and Review of the Literature (2020) (1)
- [New therapeutic approaches to autoimmune diseases]. (2006) (1)
- [Is it necessary to monitor blood hydroxychloroquine concentrations in patients with systemic lupus erythematosus?]. (2006) (1)
- Long-term outcome of 117 patients with Erdheim-Chester disease and mixed histiocytosis receiving targeted therapies (BRAF and MEK inhibitors): A monocentric experience. (2020) (1)
- AB0593 Predictors of fatigue and severe fatigue in a large multicenter international cohort of patients with systemic lupus erythematosus: the fatilup study (2018) (1)
- [Strawberry tongue and red eyes]. (2012) (1)
- [Disseminated lupus erythematosus in children: guidelines about investigations during the initial evaluation and follow-up]. (2004) (1)
- Recurrent BRAF mutations in bone marrow progenitors of patients with Erdheim-Chester disease. (2016) (1)
- Virtual cystoscopy of the urinary tract (2003) (1)
- Survival analysis versus event count (2014) (1)
- Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patients. (2021) (1)
- Response to: ‘Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease’ by Campochiaro et al (2020) (1)
- Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases) (2022) (1)
- [Coronary involvement and nephrotic syndrome in systemic lupus: A case report]. (2019) (1)
- [Interactions between corticosteroids and oral anticoagulants: a real problem]. (2001) (1)
- [Therapeutic de-escalation in systemic lupus erythematosus in remission]. (2020) (1)
- THU0584 Five years of experience with the lupus academy: an effective model for building a robust community of practice for geographically diverse learners (2017) (1)
- Profound systemic alteration of the immune phenotype and an immunoglobulin switch in Erdheim-Chester disease in 78 patients from a single center (2021) (1)
- Systemic chloroquine intoxication: peripheral blood smear can give you a hint! (2020) (1)
- ECLIPSE: a French study concerning the diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH) (2010) (1)
- Concise report Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients RHEUMATOLOGY (2012) (1)
- Severe Libman-Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated cases. (2022) (1)
- Acute Pancreatitis From Treatment With BRAF Inhibitors in Erdheim-Chester Disease: A Report From 2 Tertiary Referral Centers. (2021) (1)
- Erdheim-Chester disease: look it in the eye. An orbital magnetic resonance imaging study (2022) (1)
- Immune Reconstitution Syndrome After Nivolumab for Progressive Multifocal Leukoencephalopathy. (2020) (1)
- [Biopathology of disseminated lupus erythematosus]. (1998) (1)
- Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis. (2021) (1)
- [Autoimmune hepatitis triggered by nitrofurantoin: A rare drug-induced toxicity]. (2016) (1)
- 35 SYSTEMIC INFLAMMATORY AND AUTOIMMUNE DISEASES (SAID) ASSOCIATED WITH MDS: A FRENCH MULTICENTER RETROSPECTIVE STUDY (2015) (1)
- Intractable nausea and vomiting: gut is not always the answer. (2019) (1)
- Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) With Relapsed and Newly Diagnosed Active Lupus Nephritis (LN) (2022) (1)
- Response to: ‘Are patients with systemic lupus erythematosus at increased risk for COVID-19?’ by Favalli et al (2020) (1)
- [Premature cerebral vascular accidents after initiation of steroid therapy in Horton disease]. (2000) (1)
- Reversible Severe Eosinophilic Endomyocardial Fibrosis During Pregnancy (2015) (1)
- Response to: ‘COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine’ by Teh et al (2020) (0)
- SAT0436 Transjugular renal biopsy: a safe and effective way to perform renal biopsy in systemic lupus erythematosus and antiphospholipid antibody syndrome patients treated with anti-thrombotic drugs – a monocentric experience of 256 procedures (2018) (0)
- Error in the Abstract in the Article by Maldini et al (Arthritis Care Res [Hoboken], March 2014) (2014) (0)
- OBSERVATION Targeting Interleukin-5 in Refractory and Relapsing Churg – Strauss Syndrome (2013) (0)
- AB0675 Health related quality of life in patients with mixed connective tissue disease: A comparison with matched systemic sclerosis patients (2022) (0)
- [Chronic diffuse interstitial pneumonia associated with chronic active hepatitis. 2 cases]. (1993) (0)
- [Systemic lupus erythematosus and regulatory T cells]. (2008) (0)
- Psychiatric disorders, personality and neuropsychological alterations in Erdheim-Chester disease (2023) (0)
- THU0379 Coronary artery disease in sle: a case-controlled angiographic study (2018) (0)
- Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease (2019) (0)
- FRI0337 Factors associated with poor therapeutic adherence to hydroxychloroquine during systemic lupus (2018) (0)
- Wednesday, 29 August 2012 (2012) (0)
- [A non-automatic diagnosis]. (2002) (0)
- Scleroderma cardiac crisis and scleroderma renal crisis: Two sides of the same coin? (2022) (0)
- Insuffisance surrénalienne par nécrose bilatérale des surrénales au cours du syndrome des antiphospholipides : devenir à long terme de 16 patients (2013) (0)
- FRI0157 EPSTEIN BARR VIRUS BLOOD REPLICATION INCREASES DURING ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (2020) (0)
- Response to: ‘Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey’ by Plüß et al (2020) (0)
- ERDHEIM CHESTER DISEASE: CLINICAL PHENOTYPE AND OUTCOME. A MULTICENTRE SURVEY ECDCO01 (2010) (0)
- FRI0434 Blood Hydroxychloroquine (HCQ) Levels do not PREDICT Quality of Life in Systemic Lupus Erythematosus (SLE) (2014) (0)
- Abdominal Extrarenal Involvement in Erdheim-Chester Disease in a Cohort of 304 Patients. (2022) (0)
- 02 Macrophage activation syndrome in SLE (2019) (0)
- [When to think about lupus?]. (2011) (0)
- [Biotherapy of auto-immune diseases : past, present and future perspectives]. (2009) (0)
- Activated protein C and pulmonary embolism. (1996) (0)
- Livedo et syndrome primaire des antiphospholipides (1998) (0)
- Systemic Inflammatory and Autoimmune Diseases (SAID) Associated with MDS: A French Multicenter Retrospective Study (2014) (0)
- Les titres d’anticorps antiphosphatidylsérine/prothrombine (aPS/PT) sont fortement corrélés aux tests de recherche d’anticoagulants circulants lupiques chez les patients ayant des anticorps antiphospholipides (2011) (0)
- 101 Cardiac sarcoidosis: therapeutic management and prognostic factors from a cohort of 130 patients (2011) (0)
- SYSTEMIC CAPILLARY LEAK SYNDROME. AUTHORS' REPLY (1998) (0)
- SLE and other connective tissue diseases (human studies) (WS-016) Chairpersons: Takao Koike, Marie Wahren-Herlenius (2010) (0)
- [Contraception, fertility, pregnancy and menopause in women with systemic lupus erythematosus]. (2011) (0)
- Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus (2022) (0)
- [Gases and damages]. (1996) (0)
- Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis. (2022) (0)
- Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET (2022) (0)
- Response to: 'Circulating interferon-α measured with a highly sensitive assay as a biomarker for juvenile inflammatory myositis activity.' by Melki et al. (2019) (0)
- SAT0188 WHOLE BLOOD VERSUS SERUM HYDROXYCHLOROQUINE LEVELS FOR DRUG MONITORING OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: PRELIMINARY RESULTS OF A PHARMACOLOGICAL STUDY (2019) (0)
- Characteristics of cutaneous lupus erythematosus in Black patients, association with systemic lupus and response to treatment: a retrospective cohort study of 141 patients. (2023) (0)
- [Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008]. (2008) (0)
- In-ICU-acquired infections in flare-up systemic rheumatic disease patients receiving immunosuppressant (2022) (0)
- G.P.5.08 The prognosis of anti-synthetase syndrome is related to the lung involvement (2008) (0)
- Evaluation of Diagnostic Tools in Whippple’s Disease–Associated Uveitis : Cytological, Molecular and Microbiological Analysis (2005) (0)
- FRI0381 During antisynthetase syndrome, anti-citrullinated peptides are a marker of severe joint disease (2013) (0)
- in Active Systemic Lupus Erythematosus Global Natural Regulatory T Cell Depletion (2005) (0)
- Cd4+ Foxp3+ Cd25Bright T Regulatory Cells Population In Ocular Sarcoidosis (2012) (0)
- [Systemic lupus erythematosus: from adolescence to adulthood]. (2010) (0)
- [Systemic lupus and biotherapy: 2010 update]. (2010) (0)
- Erdheim-Chester Disease : A Monocentric Series Of 96 Patients (2013) (0)
- [Information, patient education and compliance in systemic lupus erythematosus]. (2011) (0)
- WS-016 SLE and other connective tissue diseases ( human studies ) (2010) (0)
- Anti-DNA Antibodies Receptor Involved in Cell Penetration of Calreticulin, a Potential Cell Surface (2001) (0)
- SAT0201 ASSOCIATION OF CARDIAC TROPONIN T MEASURED WITH A HIGHLY SENSITIVE ASSAY WITH CARDIOVASCULAR EVENTS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (TROPOPLUS STUDY) (2020) (0)
- Syndrome d'activation macrophagiqueau cours de la maladie de Still de l'adulte (2003) (0)
- Comparaison du syndrome des antisynthétases avec anticorps anti-PL12 (26 patients) avec le syndrome des antisynthétases avec anticorps anti-JO1 (50 patients) (2010) (0)
- Antibodies Fibroelastosis Associated with Maternal Anti-SSA / Ro and Anti-SSB / La A New Presentation of Neonatal Lupus : 5 Cases of Isolated Mild Endocardial (2011) (0)
- Response to: ‘Comments on the article: "Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial"’ by Mousavi and Taherifard (2020) (0)
- Antimalarials and SLE (2011) (0)
- SAT0399 Chronic Antigenic Stimulation and Activity of the Disease Are Predictive of Lymphoma Development in Primary SjÖgren Syndrome: A Case Control Study of 64 Cases (2015) (0)
- NT-proBNP and High-Sensitivity Cardiac Troponin T Fail to Detect Cardiac Involvement in Erdheim-Chester Disease. (2022) (0)
- [Gram-negative vascular puncture infections in patients with hemodialysis]. (1991) (0)
- [Sarcomania has its limits!]. (2004) (0)
- THU0404 Recommendations from an International Task Force for the Use of Biologics in Systemic Lupus Erythematous (2015) (0)
- Successful outcome of proliferative lupus nephritis during pregnancy: Toward a modern paradigm of lupus pregnancy? (2017) (0)
- Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms (2015) (0)
- Author ' s personal copy Medical and developmental risk factors of catatonia in children and adolescents : A prospective case – control study (2012) (0)
- [Resistance to activated protein C and portal vein thrombosis: two new cases and review of the literature]. (1999) (0)
- 18 Rare disease manifestations in SLE (2020) (0)
- Correction to: A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency (2020) (0)
- PD-1/ PD-L1 Expression Is Associated with Tissue Inflammation and BRAF Status in Erdheim-Chester Disease (2018) (0)
- [Pregnancy and antiphospholipid syndrome]. (2011) (0)
- [Systemic lupus erythematosus from 1968 to 2008: the silent revolution]. (2008) (0)
- Erdheim-Chester disease: An orbital MRI study. (2022) (0)
- TTR sequencing should be considered ahead of hypertrophic cardiomyopathy in Afro-Americans (2015) (0)
- Rapid Efficacy of anifrolumab in refractory cutaneous lupus erythematosus: a prospective study of 11 patients with systemic lupus erythematosus. (2023) (0)
- Serum vascular endothelial growth factor is associated with cardiovascular involvement and response to therapy in Erdheim-Chester disease (2022) (0)
- 162 Active Anti-IFN α Immunotherapy Applied to Chronic Viral and Autoimmune Diseases (2011) (0)
- Un diagnostic pas automatique (2002) (0)
- OP0129 CAPS CRITERIA FAIL TO IDENTIFY MOST SEVERE PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME ADMITTED TO THE INTENSIVE CARE UNITWITH A NEW THROMBOTIC MANIFESTATION (2019) (0)
- Pulmonary hyalinizing granuloma: a multicenter study of 5 new cases and review of the 135 cases of the literature (2016) (0)
- FC053: Weaning of Maintenance Immunosuppressive Therapy in Lupus Nephritis (Win-Lupus): A multicenter randomized controlled trial (2022) (0)
- Response to: ‘Withdrawal of low-dose prednisone in inactive SLE patients: is there another alternative?’ by Sabio (2020) (0)
- Reply (2020) (0)
- Response. (2020) (0)
- FRI0185 HYDROXYCHLOROQUINE FOR THE PREVENTION OF RELAPSES IN A SERIES OF 812 PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: THE HIBISCUS RETROSPECTIVE STUDY (2019) (0)
- La présence simultanée d’IgG et d’IgM anti-phosphatidylsérine/prothrombine pourrait être associée à l’occurrence de syndromes catastrophiques des antiphospholipides chez les patients porteurs d’anticorps antiphospholipides (2011) (0)
- Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy. (2022) (0)
- Erdheim-Chester disease: a single-center series of 37 patients Systemic perturbation of cytokine and chemokine networks in (2011) (0)
- The Journal of Rheumatology Anticentromere-positive Patients with Systemic Sclerosis TNFSF4 as a Susceptibility Gene Preferentially Associated with the Subset of Independent Replication and Metaanalysis of Association Studies Establish (2012) (0)
- [Sensory neuropathy and autoimmune diseases]. (2009) (0)
- [A sciatica occurring in Behçet's disease]. (2010) (0)
- Non-langerhans Cell Histiocytosis-Including Erdheim-Chester Disease- and the Lung (2015) (0)
- Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab? (2023) (0)
- The idiopathic capillary hyperpermeability syndrome (1997) (0)
- [Antiphospholipid antibodies in practice]. (2012) (0)
- Erdheim–Chester disease long‐bone osteosclerosis can be reproduced with a xenografted mouse model and its pathogenesis may involve dysregulation of bone metabolism key cytokines (2022) (0)
- Factors Associated With Posttraumatic Stress Symptoms 3 and 6 Months After Hospitalization for COVID-19: A Longitudinal Multicenter Study. (2022) (0)
- [Ear cartilage calcification]. (2000) (0)
- Systemic Sclerosis : Results from 2 Large European Caucasian Cohorts Autoimmune Risk Loci in CD 58 and ITGAM , ITGAX , Association Study of YANNICK ALLANORE (2011) (0)
- AB0323 INTIMA-MEDIA THICKNESS IS INDEPENDENTLY ASSOCIATED WITH STROKE IN PRIMARY ANTIPHOSPHOLIPID SYNDROME (2021) (0)
- [Recent findings on the genetics of Behçet's disease]. (1999) (0)
- PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study): French Results (2011) (0)
- [How to differentiate between useful and useless drugs?]. (2012) (0)
- SAT0549 Methotrexate Versus Mycophenolate Mofetil in Neurosarcoidosis: A Retrospective Trial (2015) (0)
- SAT0459 Occurrence of lymphoma in systemic lupus erythematosus: a case-series of 38 patients (2018) (0)
- 6.157 A NEW CAUSALITY ALGORITHM TO ENHANCE DIAGNOSIS AND TREATMENT OF CATATONIA DUE TO AUTOIMMUNE CONDITIONS IN CHILDREN AND ADOLESCENTS (2016) (0)
- [Patients' intervention in a therapeutic education program dedicated to systemic lupus: definitions, setting and benefits]. (2015) (0)
- [Catastrophic antiphospholipid syndrome]. (2012) (0)
- Nucleosomes play a central role in the antinuclear antibody response in lupus. Lupus anti-dsDNA and antihistone antibod- ies directed toward nucleosomes belong together with nucleo- some-specific antibodies, to a broad antinucleosome antibody family. Besides anti-dsDNA, nucleosome-specific antibodie (0)
- Th17 (WS-014) Chairpersons: Akihiko Yoshimura, Joseph E. Craft (2010) (0)
- [Antiphospholipid syndrome and atrophic polychondritis]. (1997) (0)
- Response to: ‘Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India’ by Goyal et al (2020) (0)
- Apport de la mesure de l’aire sous la courbe temps/concentration plasmatique de l’acide mycophénolique chez les patients lupiques : à propos d’une série de 103 patients consécutifs (2014) (0)
- Association of Langerhans Cell Histiocytosis with Erdheim-Chester Disease: How Close Monocyte/Macrophage and Dendritic Cell Lineages Are? (2010) (0)
- [Atheroma with 0% of fat content]. (1999) (0)
- Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients. (2022) (0)
- Comment on Gianfreda et al , page 1163 mTOR : a new target in Erdheim-Chester disease ? (2015) (0)
- Anticorps anti-DFS70 et thrombophilie (2015) (0)
- PSY17 Retrospective Chart Review Study of the Cost of Care of Systemtic Lupus Erythematousus (Sle) in Five European Countries (2011) (0)
- 17 Management of neuropsychiatric SLE (2022) (0)
- CO005Prévention primaire par aspirine de la thrombose chez les patients avec anticorps antiphospholipides : une méta-analyse collaborative internationale des données de la littérature (2012) (0)
- Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort study (2022) (0)
- Response to: ‘Patients with lupus with COVID-19: University of Michigan experience’ by Wallace et al (2020) (0)
- [Events indicative of a more serious systemic lupus immediately]. (2011) (0)
- [Neonatal lupus: a fetal-maternal immunisation model?]. (2012) (0)
- 13 Can we withdraw low-dose prednisone in remitted patients? (2020) (0)
- SAT0467 Cerebral venous thrombosis occurrence in systemic lupus erythematosus without anti-phospholipid antibody syndrome: a monocentric serie of 10 cases (2018) (0)
- 15 Strategies for minimizing corticosteroid exposure in SLE (2021) (0)
- Factors Associated with Specific Quality of Life Evolution in SLE Patients: A French Prospective Longitudinal Multicenter Study (2018) (0)
- THU0227 BIOLOGICAL MONITORING OF REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS: ABNORMAL SERUM INTERFERON-ALPHA LEVELS PREDICT RELAPSE (2019) (0)
- Détermination des conditions de culture permettant l’expansion de Tregs naïfs exprimant fortement et durablement FOXP3 in vitro à des fins thérapeutiques dans les maladies auto-immunes systémiques (2011) (0)
- Response to: ‘Glucocorticoid withdrawal in lupus: to do or not to do?’ by Acharya (2020) (0)
- NT-Probnp and High-Sensitivity Troponin T Fail to Detect Cardiac Involvement in Erdheim-Chester Disease (2022) (0)
- Hydroxychloroquine blood assay as a marker of nonadherence in patients with systemic lupus erythematosus: comment on the article by Koneru et al. (2008) (0)
- Intravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary-Leak Syndrome (Clarkson Disease). (2022) (0)
- Predictive value and clinical interest of the antiphospholipid score: comment on the article by Otomo et al. (2012) (0)
- AB0038 IMMUNE PHENOTYPING OF ERDHEIM-CHESTER DISEASE THROUGH MASS CYTOMETRY (2020) (0)
- MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis (2021) (0)
- Pulmonary Involvement in Takayasu Arteritis and Behçet Disease (2015) (0)
- Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia (2022) (0)
- Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicenter cohort study. (2022) (0)
- The eclipse sign as a radiological presentation of neurosarcoidosis (2020) (0)
- Potentialisation des anticoagulants oraux par l’injection intraveineuse de fortes doses de glucocorticoïdes (1999) (0)
- Prévention primaire de la thrombose par aspirine chez les patients porteurs d’anticorps antiphospholipides : analyse poolée des données individuelles de 5 cohortes internationales (2013) (0)
- PO.5.101 The effect of belimumab on renal outcomes in a pre-specified subgroup analysis of a phase 3 randomised trial in a european population with lupus nephritis (2022) (0)
- Response to: ‘Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus’ by Kondo et al (2020) (0)
- FRI0336 Belief about medicine questionnaire predicts therapeutic adhesion to hydroxychloroquine during systemic lupus erythematosus (2018) (0)
- SAT0449 Juvenile onset systemic lupus erythematosus outcome in adulthood: a monocentric retrospective cohort (2018) (0)
- PD-1/PD-L1 expression is frequent and correlated with lymphocyte density in Erdheim-Chester disease (2022) (0)
- Mycophenolate or azathioprine maintenance in lupus nephritis. (2012) (0)
- Treatment of Erdheim-Chester disease patients with the MEK inhibitor cobimetinib. (2016) (0)
- Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: a registry-based cohort study of 164 patients. (2022) (0)
- Vasculitis and familial Mediterranean fever: Description of 22 French adults from the juvenile inflammatory rheumatism cohort (2022) (0)
- List of Contributors (2019) (0)
- RARE SYSTEMIC HEMATOLOGIC DISORDERS Erdheim-Chester disease (2020) (0)
- FRI0262 Monitoring disease activity in systemic lupus erythematosus with digital elisa quantification of serum interferon-Α (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Zahir Amoura?
Zahir Amoura is affiliated with the following schools:
